Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jua Choi

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|August 17, 2016
Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximabJoseph Kahwaji, Stanley C Jordan, Reiad Najjar, et al.
Transplantation|April 3, 2020
Interleukin-6: An Important Mediator of Allograft InjuryStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Transplantation|January 22, 2015
Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After DesensitizationAshley A Vo, Aditi Sinha, Mark Haas, et al.
Kidney International|January 21, 2017
Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodiesMark Haas, James Mirocha, Nancy L Reinsmoen, et al.
Pediatric Transplantation|September 28, 2022
Pre-transplant angiotensin II receptor type I antibodies in pediatric renal transplant recipients: An observational cohort studyHelen Pizzo, James Mirocha, Jua Choi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2019
Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant RecipientsEdmund Huang, Ashley Vo, Jua Choi, et al.
Transplantation|September 25, 2018
Novel Therapeutic Approaches to Allosensitization and Antibody-mediated RejectionStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 25, 2022
Viral-specific cytotoxic T-cell responses in HLA-sensitized kidney transplant patients maintained on everolimus and low-dose tacrolimusShili Ge, Maggie Chu, Jacqueline Tang, et al.
Transplantation|April 29, 2014
Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipientsAshley A Vo, Jua Choi, Kristen Cisneros, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2020
The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejectionStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Transplant International : Official Journal of the European Society for Organ Transplantation|August 17, 2016
Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximabJoseph Kahwaji, Stanley C Jordan, Reiad Najjar, et al.
Transplantation|April 3, 2020
Interleukin-6: An Important Mediator of Allograft InjuryStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Transplantation|January 22, 2015
Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After DesensitizationAshley A Vo, Aditi Sinha, Mark Haas, et al.
Kidney International|January 21, 2017
Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodiesMark Haas, James Mirocha, Nancy L Reinsmoen, et al.
Pediatric Transplantation|September 28, 2022
Pre-transplant angiotensin II receptor type I antibodies in pediatric renal transplant recipients: An observational cohort studyHelen Pizzo, James Mirocha, Jua Choi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2019
Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant RecipientsEdmund Huang, Ashley Vo, Jua Choi, et al.
Transplantation|September 25, 2018
Novel Therapeutic Approaches to Allosensitization and Antibody-mediated RejectionStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 25, 2022
Viral-specific cytotoxic T-cell responses in HLA-sensitized kidney transplant patients maintained on everolimus and low-dose tacrolimusShili Ge, Maggie Chu, Jacqueline Tang, et al.
Transplantation|April 29, 2014
Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipientsAshley A Vo, Jua Choi, Kristen Cisneros, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2020
The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejectionStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Pageof 4